ArticleClinical drug investigation2026

Clinical Benefit of Multiple Myeloma Drugs at Regulatory Approval in Brazil, Europe, and the USA: A Retrospective Cohort Study (2003-2024).

Marina Alacoque Rodrigues et al.PubMed ↗Publisher ↗

No numbers read from the abstract.